The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...

Though late to the party compared to other industry leaders, Abbott joins a pulsed field ablation market poised for ...

The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, ...

University of Michigan labs are using advanced technology to help people like quadriplegics and amputees lead fuller lives ...

The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced it received CE mark approval in Europe for its ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.

The FDA has approved Valcare Medical’s IDE application, allowing it to begin an EFS of Amend Trans-Septal System.

Abbott (ABT) announced that the U.S. Food and Drug Administration, FDA, has approved an investigational device exemption, IDE, for its Coronary ...

Abbott begins new Intravascular Lithotripsy trial to improve outcomes in patients with coronary artery disease: Abbott Park, Illinois Wednesday, March 26, 2025, 15:00 Hrs [IST] Ab ...

Lungpacer Medical, a leading neurostimulation company committed to advancing therapies that assist patients in overcoming the negative effects of mechanical ventilation (MV), is excited to announce ...